Genetically engineered stem cell therapy for tissue regeneration

Annals of the New York Academy of Sciences

Volumn 1015, Issue , 2004, Pages 271-284

  Alessandri, Giulio ^a   Emanueli, Costanza ^b   Madeddu, Paolo ^b,c  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

Author keywords

Angiogenesis; Cell engineering; Gene therapy; Stem cells; Vasculogenesis

Indexed keywords

RECOMBINANT DNA; VIRUS VECTOR;

ANGIOGENESIS; CONFERENCE PAPER; DEGENERATIVE DISEASE; DNA MODIFICATION; ENDOTHELIUM CELL; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GENETIC MANIPULATION; HUMAN; IMMUNE RESPONSE; NERVE CELL NECROSIS; NERVE FIBER; NONHUMAN; PERIPHERAL ISCHEMIA; PULMONARY HYPERTENSION; RECURRENT DISEASE; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOSIS; TISSUE REGENERATION;

EID: 3042754678     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1302.023     Document Type: Conference Paper

References (67)

1. NABEL, E. 2001. Stem cells combined with gene transfer for therapeutic vasculogenesis. Magic bullets? Circulation 105: 672-674.
2. RISAU, W. 1997. Mechanism of angiogenesis. Nature 386: 671-674.
3. 2 homeostasis. Curr. Opin. Genet. Dev. 8: 588-594.
4. FERRARA, N. & T. DEVIS-SMYTH. 1997. The biology of vascular endothelial growth factor. Endocrinol. Rev. 18: 4-25.
5. WITZENBICHLER, B., et al. 1998. Vascular endothelial growth factor-C (VEGF-C/ VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. 153: 381-394.
6. FERRARA, N. & K. ALITALO. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5: 1359-1364.
7. SURI, C., et al. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282: 468-471.
8. CHAE, J.K., et al. 2000. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler. Thromb. Vasc. Biol. 20: 2573-2578.
9. MAISONPIERRE, P.C., et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
10. BUSSOLINO, F., et al. 1997. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22: 251-256.
11. HANAHAN, D. 1997. Signaling vascular morphogenesis and maintenance. Science 277: 48-50.
12. EMANUELI, C. 2000. Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Arterioscler. Thromb. Vasc. Biol. 20: 2379-2385.
13. EMANUELI, C., et al. 2001. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 103: 125-132.
14. TSCHOPE, C., et al. 2000. Upregulation of bradykinin B1-receptor expression after myocardial infarction. Br. J. Pharmacol. 129: 1537-1538.
15. EMANUELI, C., et al. 2002. Targeting kinin B1 receptor for therapeutic neovascularization. Circulation 105: 360-366.
16. MAESTRI, R., et al. 2003. Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension 41: 1151-1155.
17. EMANUELI, C., et al. 2002. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106: 2257-2262.
18. ASAHARA, T. 1999. Bone marrow origin of endothelial progenitor cells responsible for post-natal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85: 221-228.
19. ASAHARA, T. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 965-967.
20. + endothelial precursor cells. Circ. Res. 88: 167-174.
21. SHINTANI, S., et al. 2001. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776-2779.
22. RAFII, S., et al. 2002. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther. 9: 631-641.
23. PELOSI, E., et al. 2002. Identification of the hemangioblast in postnatal life. Blood 100: 3203-3208.
24. ASAHARA, T., et al. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18: 3964-3972.
25. BAUTZ, P., et al. 2000. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells: possible role in the hematopoietic microenvironment. Exp. Hematol. 28: 700-706.
26. TAKAHASHI, T., et al. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5: 434-438.
27. HEISSIG, B., et al. 2002 Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
28. YAMAGUCHI, J., et al. 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1325.
29. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91: 4523-4530.
30. EMANUELI, C. & P. MADEDDU. 2001. Angiogenesis gene therapy to rescue ischemic tissues: achievements and future directions. Br. J. Pharmacol. 133: 951-958.
31. RIVARD, A., et al. 1999. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 154: 355-363.
32. VAN BELLE, E., et al. 1997. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 96: 2667-2674.
33. EMANUELI, C., et al. 2002. Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation 106: 993-999.
34. RIVARD, A., et al. 1999. Age-dependent impairment of angiogenesis. Circulation 99: 111-120.
35. MURAYAMA, T., et al. 2001. Aging impairs therapeutic contribution of human endothelial progenitor cells to postnatal neovascularization. Circulation 104: 11-68.
36. MASUDA, H. & T. ASAHARA. 2003. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc. Res. 93: 162-169.
37. VASA, M., et al. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89: E1-E7.
38. HILL, J.M., et al. 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348: 593-600.
39. FERRARA, N. & K. ALITALO. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5: 1359-1364.
40. HENRY, T.D. & J.A. ABRAHAM. 2000. Review of preclinical and clinical results with vascular endothelial growth factors for therapeutic angiogenesis. Curr. Interv. Cardiol. Rep. 2: 228-241.
41. ORLIC, D., et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
42. MUROHARA, T., et al. 2000. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105: 1527-1536.
43. KAWAMOTO, A., et al. 2001. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637.
44. KALKA, C., et al. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97: 3422-3427.
45. KOCHER, A.A., et al. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7: 430-436.
46. ASSMUS, B., et al. 2002. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017.
47. REHMAN, J., et al. 2003. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
48. CROSBY, J.R., et al. 2000. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res. 87: 728-730.
49. HARRAZ, M., et al. 2001. CD34- blood-derived human endothelial cell progenitors. Stem Cells 19: 301-312.
50. IWAGURO, H., et al. 2001. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738.
51. MUROHARA, T., et al. 2000. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105: 1527-1536.
52. MURASAWA, S., et al. 2001. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106: 1133-1139.
53. PEICHEV, M., et al. 2000. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
54. ZIEGLER, B., et al. 1999. KDR receptor: a key marker defining hematolymphopoietic stem cells. Science 285: 1553-1558.
55. KAY, M.A., et al. 2001. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7: 33-40.
56. MIGNATTI, P., et al. 1991. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc. Natl. Acad. Sci. USA 88: 11007-11011.
57. DELLAMBRA, E., et al. 1998. Corrective transduction of human epidermal stem cells in laminin 5-dependent junctional epidermolysis bullosa. Hum. Gene Ther. 9: 1359-1370.
58. NAGAYA, N., et al. 2003. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitors cells. Circulation 108: 889-895.
59. GRIESE, D.P., et al. 2003. Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells. Cardiovasc. Res. 58: 469-477.
60. NAKATOMI, H., et al. 2002. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110: 429-441.
61. LINDVALL, O., et al. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247: 574-577.
62. LAX, J.D., et al. 1998. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16: 1033-1039.
63. GALLI, R., et al. 2003. Neural stem cells: an overview. Circ. Res. 9: 598-608.
64. PARATI, E.A., et al. 2002. Human neural stem cells express extra-neural markers. Brain Res. 925: 213-221.
65. GROVES, A.K., et al. 1993. Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells. Nature 362: 453-455.
66. ANDSBERG, G., et al. 1998. Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells. Eur. J. Neurosci. 10: 2026-2036.
67. ALESSANDRI, G., et al. 2001. Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab. Invest. 81: 875-885.